Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (4), 377-385
- https://doi.org/10.1016/s0928-0987(00)00158-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infectionAIDS, 1999
- Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudineThe Lancet, 1998
- A Single-Dose Study to Assess the Penetration of Stavudine Into Human Cerebrospinal Fluid in AdultsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- In Vitro Blood–Brain Barrier Permeability of Nevirapine Compared to Other HIV Antiretroviral AgentsJournal of Pharmaceutical Sciences, 1998
- Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complexAntimicrobial Agents and Chemotherapy, 1995
- Genotypic And Phenotypic Analysis Of Human Immunodeficiency Virus Type 1 Isolates From Patients On Prolonged Stavudine TherapyThe Journal of Infectious Diseases, 1994
- High-performance liquid chromatographic determination of 2′,3′-didehydro-3′-deoxythymidine, a new anti-human immunodeficiency virus agent, in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- [On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9.] Comment: Neyman (1923) and Causal Inference in Experiments and Observational StudiesStatistical Science, 1990
- The Brain in AIDS: Central Nervous System HIV-1 Infection and AIDS Dementia ComplexScience, 1988